Quarterly Result12 Feb 2026, 11:41 am
Lincoln Pharmaceuticals Ltd. Announces Q3 and Nine Months Financial Results for 2025
AI Summary
Lincoln Pharmaceuticals Ltd. has announced its unaudited financial results for the quarter and nine months ended on 31st December 2025. The Board of Directors approved the standalone and consolidated financial results in their meeting held on 12th February 2026. The company's revenue from operations stands at 16,632.20 lakhs for the quarter and 48,375.26 lakhs for the nine months ended on 31st December 2025.
Key Highlights
- Revenue from operations for the quarter is 16,632.20 lakhs
- Nine months revenue from operations is 48,375.26 lakhs
- Board of Directors approved the standalone and consolidated financial results
- Limited review of financial results conducted by the auditor
Price Impact
More from LINCOPH